Ranbaxy Laboratories Limited

Products

Full Paper

Full Paper

Price: £95.00
Description: The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.



Research Report Overview

Published Date: 08/06/2011
Category: Therapies & Markets

Research Report Decription

Ranbaxy Laboratories Limited - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Features:

  • Detailed information on Ranbaxy Laboratories Limited required for business and competitor intelligence needs
  • A study of the major internal and external factors affecting Ranbaxy Laboratories Limited in the form of a SWOT analysis
  • An in-depth view of the business model of Ranbaxy Laboratories Limited including a breakdown and examination of key business segments
  • Intelligence on Ranbaxy Laboratories Limited’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
  • News about Ranbaxy Laboratories Limited, such as business expansion, restructuring, and contract wins
  • Large number of easy-to-grasp charts and graphs that present important data and key trends

Key Questions Answered:

  • Gain understanding of the Ranbaxy Laboratories Limited and the factors that influence its strategies
  • Track strategic initiatives of the company and latest corporate news and actions 
  • Assess Ranbaxy Laboratories Limited as a prospective partners, vendor or supplier
  • Support sales activities by understanding your customers' businesses better
  • Stay up to date on Ranbaxy Laboratories Limited’s business structure, strategy and prospects

Companies Mentioned:

Ranbaxy Laboratories Ltd

Paper Highlights:

Ranbaxy Laboratories (Ranbaxy) is an India-based company. The company, with its subsidiaries, operates as an integrated international pharmaceuticals organization with businesses encompassing the value chain in the marketing, production and distribution of pharmaceuticals products. The company operates in India, Europe, North America and Asia Pacific. It is headquartered in Gurgaon, India and employs 12,995 people. The company recorded revenues of INR75,970.4 million (approximately $1,570.3 million) during the financial year (FY) ended December 2009, an increase of 2.5% over FY2008. The operating profit of the company was INR11,991 million (approximately $247.9 million) during FY2009, compared to an operating loss of INR2,626.3 (approximately $54.3 million) in FY2008. The net profit was INR2,964.9 million (approximately $61.3 million) in FY2009, compared to a net loss of INR9,512.1 (approximately $196.6 million) in FY2008. * Calculated using the constant currency conversion rate of INR1 = $0.02067 for the financial year ended December 2009